Wuhan UNscience Biotechnology Co., Ltd.

Wuhan UNscience Biotechnology Co., Ltd, specializes in the research and development, production and sale of in-vitro diagnostic reagents. Certified with ISO 13485:2016 , CE registered in UK MHRA(Medicines & Healthcare products Regulatory Agency , UNscience sells its products all over the world). Presently UNscience also passed FDA notification in USA. UNscience has 100,000 grade GMP purification workshop and quality management system, three major technical platforms including Colloidal Gold Immunochromatographic Platform, Fluorescence Immunochromatographic Platform, and Pathological Diagnosis Antibody Platform. UNscience has independent research and development and production capacity of core raw materials, and has successfully developed 35 POCT immunochromatographic quantitative detection products (colloidal gold and fluorescence), mainly covering cardiovascular and cerebrovascular diseases, kidney diseases, diabetes, infectious diseases, reproductive health, health examination and other. Its POCT products have obtained NMPA(National Medical products Administration) license. With the outbreak of Novel Coronavirus (COVID-19), with fast work by the R&D team of UNscience, UNscience had successfully finished developing the antibody detection kit against the COVID-19 virus. This kit was based on colloidal gold immunochromatographic method. The operation is simple and fast, and the results can be obtained in 10 minutes.